Umbilical cord blood: Current status & promise for the future

Indian Journal of Medical Research

Volumn 134, Issue 9, 2011, Pages 261-269

  Mckenna, David ^a   Sheth, Jayesh ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Foundation for Research in Genetics and Endocrinology   (India)

Author keywords

Haematopoietic reconstitution; Stem cells; Umbilical cord blood (UCB)

Indexed keywords

ACCREDITATION; ACUTE LYMPHOBLASTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; BRAIN INJURY; CORD BLOOD STEM CELL TRANSPLANTATION; ETHICS; EYE DISEASE; GRAFT VERSUS HOST REACTION; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEART INFARCTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MEDICAL SOCIETY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REDUCED INTENSITY CONDITIONING; REGENERATIVE MEDICINE; STEM CELL EXPANSION; STORAGE DISEASE; THALASSEMIA; TISSUE ENGINEERING; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

BLOOD BANKS; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INDIA;

EID: 80054725351     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Cohen Y, Nagler A. Umbilical cord blood transplantation - how, when and for whom? Blood Rev 2004; 18: 167-79.
2. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006; 12: 184-94.
3. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-85.
4. Bensinger W. I, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-800.
5. Cohen Y, Nagler A. cord blood biology & transplantation. Isr Med Assoc J 2004; 6: 39-46.
6. Cohen Y, Nagler A. Hematopoietic stem-cell transplantation using umbilical cord blood. Leuk Lymphoma 2003; 44: 1287-99.
7. Lusin BH, Shearer WT. American Academy of Pediatrics section on Hematology/Oncology; American Academy of Pediatrics section on Allergy/immunology. Cord blood banking for potential future transplantation. Pediatrics 2007; 119: 165-70.
8. McCullough J, McKenna D, Kadidlo D, Schierman T, Wagner J. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion 2005; 45: 832-41.
9. Banks. Standards for cellular therapy product services, 2nd ed. Bethesda MD: American Association of Blood Banks; 2007.
10. Net Cord Foundation for the Accreditation of Cellular Therapy10. International standards for cord blood collection, processing, testing, banking, selection and release. 3rd ed. Bethesda, MD: American Association of Blood Banks; 2006.
11. Steinbrook R. The cord-blood bank controversies. N Engl J Med 2004; 351: 2255-7.
12. World Marrow Donor Association. Stem cell registries annual report, 10th ed. Leiden: World Marrow Donor Association;
13. http://www.worldmarrow.org/fileadmin/WorkingGroups_Subcommittees/Cord_Blood_Working_Group/Cord_Blood_Banks_Worldwide_13042010.pdf, accessed on September 12, 2010.
14. Tomblyn MB, Arora M, Baker KS, Blazar BR, Brunstein CG, Burns LJ, et al. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol 2009; 27: 3634-41.
15. Ponce D, Zheng J, Gonzales AM, Castro-Malaspina HR, Hsu KC, Jakubowski A, et al. Disease-free survival after cord blood (CB) transplantation is not different to that after related or unrelated donor transplantation in patients with hematologic malignancies. 51st ASH Annual Meeting and Exposition - On Line Programme and Abstracts. 2009; Abstract no. 2296.
16. Gutman JA, Leisenring W, Appelbaum FR, Woolfrey AE, Delaney C. Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis. Biol Blood Marrow Transplant 2009; 15: 1122-9.
17. Harris DT. Non-haematological user of cord blood stem cells. Br J Haematol 2009; 147: 177-84.
18. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, et al. Eurocord Transplant Group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137-43.
19. Jaing TH, Hung IJ, Yang CP, Tsai MH, Lee WI, Sun CF. Second transplant with two unrelated cord blood units for early graft failure after cord blood transplantation for thalassemia. Pediatr Transplant 2009; 13: 766-8.
20. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris R, Wagner J, et al. Results of unrelated cord blood transplant in Fanconi Anemia patients: Risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073-82.
21. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008; 112: 2979-89.
22. Umbilical cordblood. Available from: http://parentsguidecordblood.org/content/usa/banklists/summary.shtml# india last modified on 13th Sept. 2010 accessed on September 14, 2010.
23. Barker JN. Umbilical Cord Blood (UCB) transplantation: an alternative to the use of unrelated volunteer donors? Hematology Am Soc Hematol Educ Program 2007; 55-61.
24. Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S. Private cord blood banking: Experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics 2009; 123: 1011-7.
25. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-60.
26. Gluckman E., Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from HLA-identical sibling. N Engl J Med 1989; 321: 1174-8.
27. Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, et al; Quality Assurance and Clinical Working Groups of the World Marrow Donor Association. Hematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant 2008; 42: 9-14.
28. Cord blood Registry. Why you should save cord blood for your family. Available from: http://www.cordblood.com/cord_blood_banking_with_cbr/banking/diseases_treated.asp?fbid=BlyS_OAIG4n, accessed on April 13, 2010.
29. [No authors listed]. Private cord blood banks. Med Lett Drugs Ther 2004; 46: 21-2.
30. http://www.savethechildren.in/87-news-releases/130-child-mortality-in-india.html, accessed on August 18, 2011.
31. Viacord. Using stem cells to potentially treat heart disease. Available from: www.viacord.com/stem-cells-heart-disease.htm, accessed on September 14, 2010.
32. Armson BA; Maternal Fetal Medicine Committee, Society of Obstetricians and Gynecologists of Canada. Umbilical cord blood banking: implications for perinatal care providers. J Obstet Gynaecol Can 2005; 27: 263-90.
33. ICMR-DBT guidelines for stem cell Research & Therapy. 2006; http://medind.nic.in/iby/t06/i9/ibyt06i9p371.pdf, accessed on September 14,
34. http://www.parentsguidecordblood.org/content/usa/banklists/regulations.shtml?navid=31#india last updated. April 23 2010, accessed on September 14,
35. http://www.iom.edu/en/Activities/Research/Cordblood Bank.aspx, accessed on November 22, 2010.
36. Opinion No 19. http://ec.europa.eu/european_group_ethics/docs/avis19_en.pdf, European Union group on ethics, accessed on November 22, 2010.
37. Cetrulo CL. Cord-blood mesenchymal stem cells and tissue engineering. Stem Cell Rev 2006; 2: 163-8.
38. Janic B, Guo AM, Iskander AS, Varma NR, Scicli AG, Arbab AS. Human cord blood derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One2010; 5: e9173.
39. Li S, Sun Z, Lv G, Guo X, Zhang Y, Yu W, et al. Microencapsulated UCB cells repair hepatic injure byintraperitoneal transplantation. Cytotherapy 2009; 11: 1032-40.
40. Cord Blood for Neonatal Hypoxic-Ischemic Encephalopathy, Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy Study Phase I Study of Feasibility and Safety http://clinicaltrials.gov/ct2/show/NCT00593242, accessed on August 18, 2011.
41. Haller M. J, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008; 36: 710-5.
42. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Sanberg DC, Sanberg PR, et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006; 199: 191-200.
43. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005; 14: 595-604.
44. Harris DT, He H, Gaballa M. The potential of cord blood stem cells for use in regenerative medicine of the heart. 2nd International Stem Cells Meeting, San Francisco, CA, 22-24 January 2007.
45. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-8.
46. Harris DT, He X, Badowski M, Nicols JC. Regenerative Medicine of the eye: a Short review. In: Levicar N, Habib NA, Dimarakis I, Gordon MY, editors. Stem cell repair & regeneration, vol. London: Imperial College Press; p. 211-25.
47. Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007; 137: 20-35.
48. Peled T, Mandel J, Goudsmid RN, Landor C, Hasson N, Harati D, et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy 2004; 6: 344-55.
49. Deutsch V, Hubel E, Kay S, Ohayon T, Katz BZ, Many A, et al. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood. Br J Haematol 2010; 149: 137-49.
50. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232-6.
51. McKenna DH, Kadidlo DM, Miller JS, Orchard PJ, Wagner JE, McCullough J. The Minnesota Molecular and Cellular Therapeutic Facility: a state of the art biotherapeutics engineering laboratory. Transfus Med Rev 2005; 19: 217-28.
52. Madlambayan GJ, Rogers I, Purpura KA, Ito C, Yu M, Kirouac D, et al. Clinically relevant expansion of hematopoietic stem cells with conserved function in a single use, closed system bioprocess. Biol Blood Marrow Transplant 2006; 12: 1020-30.
53. Delaney C, Heimfeld S, Basdhem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution Nat Med 2010; 16: 232-6.
54. Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R. Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion dependant Thalassemia. Bone Marrow Transplant 2007; 40: 307-11.
55. Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, Blazar BR, et al. In vitro-expanded human CD4(+) CD25(+) T-regulatory cells can markedly inhibit allogenic dendritic cell- stimulated MLR cultures. Blood 2004; 104: 453-61.
56. Brunstein CG, Hippen K, McKenna DH, Cao Q, Miller JS, Blazar BR, et al. Ex vivo expanded umbilical cord blood (UCB)-derived regulatory cells to recipients of non-myeloablative unrelated double UCB transplantation. Blood (ASHG American Society of Hematology Annual meeting abstracts) 2009; 114: Abstract no. 513.
57. Tolar J, Hippen KL, Blazar BR. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematolo 2009; 147: 200-6.
58. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation Blood 2007; 110: 2764-7.